New Anticoagulant Pill Works Well in Trial

Related Encyclopedia • Alzheimer's Disease • Aneurysms • Angina Pectoris • Angiogram More... Related Healthscout Videos The Cure Within DVT: What You Need to Know Killing Ourselves Killing Ourselves More... Related Animations • Alzheimer's Disease Video Animation • Angioplasty • Coronary Bypass Surgery • Erectile Dysfunction More... Related Drug Information • Accupril • Actonel • Altace • Avapro More... Related News Articles • Making Your Way Through the Fog of Chemotherapy • Health Tip: When Your Blood Clots Excessively • Bursts of Vigorous Activity Appear to Be a 'Stress-Buffer' • Toothbrushing May Stave Off Heart Woes More...

Page:  << Prev | 1 | 2 | 3

"The trends toward benefit with rivaroxaban, as a fixed-dose, direct and oral factor Xa inhibitor, provide a sound rationale to pursue a path of further investigation," Becker said.

The dose-related bleeding risk supports a strategy of lower doses than would be used for other potential indications for the drug, such as atrial fibrillation and venous thrombosis, he said.

"In the next several years, the field will have a wealth of information on antithrombotic therapies, providing a platform to determine optimal treatment in a wide range of patients with acute coronary syndrome," Becker said.

Text Continues Below

---

More information

For more information on anticoagulants, visit the American Heart Association.

Page:  << Prev | 1 | 2 | 3